USD 131.87
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 11.64 Million USD | -51.31% |
2022 | 23.92 Million USD | 200.95% |
2021 | 7.94 Million USD | 12.64% |
2020 | 7.05 Million USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | -100.0% |
2016 | 1.00 USD | 0.0% |
2015 | 1.00 USD | 0.0% |
2014 | - USD | -100.0% |
2013 | 1.00 USD | 0.0% |
2012 | 1.00 USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 15.94 Million USD | 36.94% |
2024 Q3 | 23.53 Million USD | 17.21% |
2024 Q2 | 20.08 Million USD | 25.91% |
2023 Q4 | 11.64 Million USD | -72.91% |
2023 FY | 11.64 Million USD | -51.31% |
2023 Q1 | 28.34 Million USD | 18.48% |
2023 Q2 | 41.89 Million USD | 47.82% |
2023 Q3 | 42.98 Million USD | 2.6% |
2022 Q3 | 23.59 Million USD | -5.69% |
2022 Q1 | 7.89 Million USD | -0.69% |
2022 FY | 23.92 Million USD | 200.95% |
2022 Q4 | 23.92 Million USD | 1.37% |
2022 Q2 | 25.02 Million USD | 217.02% |
2021 Q4 | 7.94 Million USD | -2.68% |
2021 Q2 | 7.76 Million USD | 2.5% |
2021 FY | 7.94 Million USD | 12.64% |
2021 Q3 | 8.16 Million USD | 5.12% |
2021 Q1 | 7.57 Million USD | 7.41% |
2020 Q4 | 7.05 Million USD | 139.43% |
2020 FY | 7.05 Million USD | 0.0% |
2020 Q3 | 2.94 Million USD | 26.21% |
2020 Q2 | 2.33 Million USD | 67.85% |
2020 Q1 | 1.39 Million USD | 0.0% |
2019 FY | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | -100.0% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | -100.0% |
2017 Q3 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q4 | 1.00 USD | 0.0% |
2016 Q1 | - USD | -100.0% |
2016 FY | 1.00 USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q4 | 1.00 USD | 0.0% |
2015 Q2 | - USD | -100.0% |
2015 Q1 | 1.00 USD | 0.0% |
2015 FY | 1.00 USD | 0.0% |
2014 Q4 | - USD | -100.0% |
2014 Q1 | - USD | -100.0% |
2014 Q2 | 1.00 USD | 0.0% |
2014 FY | - USD | -100.0% |
2014 Q3 | 1.00 USD | 0.0% |
2013 Q2 | 1.00 USD | 0.0% |
2013 FY | 1.00 USD | 0.0% |
2013 Q4 | 1.00 USD | 0.0% |
2013 Q1 | - USD | -100.0% |
2013 Q3 | 1.00 USD | 0.0% |
2012 Q4 | 1.00 USD | 0.0% |
2012 FY | 1.00 USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Cosmos Health Inc. | 4.78 Million USD | -143.2% |
Safety Shot Inc | 1.86 Million USD | -522.952% |
Bright Green Corporation | - USD | -Infinity% |
Embecta Corp. | 152.1 Million USD | 92.343% |
ANI Pharmaceuticals, Inc. | 111.19 Million USD | 89.526% |
Aquestive Therapeutics, Inc. | 6.76 Million USD | -72.064% |
Collegium Pharmaceutical, Inc. | 32.33 Million USD | 63.977% |
Dynavax Technologies Corporation | 53.29 Million USD | 78.144% |
Esperion Therapeutics, Inc. | 65.62 Million USD | 82.252% |
Pacira BioSciences, Inc. | 104.35 Million USD | 88.839% |
PainReform Ltd. | - USD | -Infinity% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -103.095% |
Sunshine Biopharma, Inc. | 5.73 Million USD | -103.095% |
SCYNEXIS, Inc. | - USD | -Infinity% |
China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -1338.333% |
Journey Medical Corporation | 10.2 Million USD | -14.119% |
Alpha Teknova, Inc. | 11.59 Million USD | -0.457% |
Procaps Group, S.A. | 96.83 Million USD | 87.972% |
Theratechnologies Inc. | 6.06 Million USD | -92.005% |
Harrow Health, Inc. | 10.86 Million USD | -7.178% |
Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -328.356% |
Biofrontera Inc. | 10.9 Million USD | -6.775% |
DURECT Corporation | 2.21 Million USD | -424.876% |
Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 84.954% |
Cronos Group Inc. | 30.33 Million USD | 61.61% |
OptiNose, Inc. | 8.05 Million USD | -44.647% |
Ironwood Pharmaceuticals, Inc. | 1.00 USD | -1164699900.0% |
Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
RedHill Biopharma Ltd. | 5.69 Million USD | -104.368% |
Organogenesis Holdings Inc. | 28.25 Million USD | 58.776% |
Guardion Health Sciences, Inc. | 2.67 Million USD | -335.058% |
Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -152.681% |
Radius Health, Inc. | 278.64 Million USD | 95.82% |
Universe Pharmaceuticals INC | 3.34 Million USD | -248.372% |
ProPhase Labs, Inc. | 3.84 Million USD | -203.228% |
Phibro Animal Health Corporation | 265.91 Million USD | 95.62% |
Procaps Group S.A. | 96.83 Million USD | 87.972% |
Alvotech | 74.43 Million USD | 84.352% |
TherapeuticsMD, Inc. | - USD | -Infinity% |
Viatris Inc. | 3.46 Billion USD | 99.664% |
Rockwell Medical, Inc. | 5.87 Million USD | -98.382% |
Aytu BioPharma, Inc. | 12.63 Million USD | 7.805% |
SIGA Technologies, Inc. | 64.21 Million USD | 81.863% |
Tilray Brands, Inc. | 252.08 Million USD | 95.38% |
Lifecore Biomedical, Inc. | 39.97 Million USD | 70.867% |
Shineco, Inc. | 1.58 Million USD | -633.196% |
PetIQ, Inc. | 159.3 Million USD | 92.689% |
Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 7723.48% |
Incannex Healthcare Limited | -10.01 Million USD | 216.296% |
Neurocrine Biosciences, Inc. | 38.3 Million USD | 69.59% |
Alimera Sciences, Inc. | 1.87 Million USD | -519.851% |
Silver Spike Investment Corp. | - USD | -Infinity% |
Assertio Holdings, Inc. | 37.68 Million USD | 69.095% |
Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
Petros Pharmaceuticals, Inc. | 1.61 Million USD | -623.241% |
Clever Leaves Holdings Inc. | 4.48 Million USD | -159.804% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -4479.087% |
Avadel Pharmaceuticals plc | 10.38 Million USD | -12.206% |
Hempacco Co., Inc. | 2.54 Million USD | -358.069% |
Talphera, Inc. | - USD | -Infinity% |
Alvotech | 74.43 Million USD | 84.352% |
Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 75.631% |
Lantheus Holdings, Inc. | 64.02 Million USD | 81.81% |
Currenc Group, Inc. | 732.91 Thousand USD | -1489.142% |
Kamada Ltd. | 87.74 Million USD | 86.727% |
Indivior PLC | 141.79 Million USD | 91.786% |
Evoke Pharma, Inc. | 481.84 Thousand USD | -2317.192% |
Flora Growth Corp. | 8.5 Million USD | -36.895% |
Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -4479.087% |
Evolus, Inc. | 10.99 Million USD | -5.901% |
HUTCHMED (China) Limited | 50.25 Million USD | 76.826% |
Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 88.995% |
Akanda Corp. | 1.28 Million USD | -805.047% |